首页> 外文期刊>Antimicrobial agents and chemotherapy. >Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011
【24h】

Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011

机译:2010-2011年韩国女性泌尿道感染的抗菌药物敏感性模式和流行病学

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study aimed to (i) investigate the antimicrobial susceptibilities of bacteria that cause urinary tract infections (UTIs) in outpatient and inpatient settings and (ii) evaluate the risk factors for emerging antimicrobial drug resistance in UTIs in South Korea. In total, 3,023 samples without duplication were collected from females between 25 and 65 years of age who had been diagnosed with a urinary tract infection. Multicenter patient data were collected using a Web-based electronic system and then evaluated. The isolation rates of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium in the outpatient setting were 78.1, 4.7, and 1.3%, respectively; in the inpatient setting, the isolation rates of these microorganisms were 37.8, 9.9, and 14.8%, respectively. The susceptibilities of E. coli to amikacin, amoxicillin- clavulanic acid, cefotaxime, cefoxitin, ciprofloxacin, piperacillin-tazobactam, and imipenem in the outpatient setting were 99.4, 79.8, 89.4, 92.8, 69.8, 96.9, and 100.0%, respectively; in the inpatient setting, the susceptibilities to these antibiotics were 97.8, 73.9, 73.7, 82.1, 53.6, 93.2, and 100.0%, respectively. The most unique and common risk factor for emerging antimicrobial-resistant E. coli, K. pneumoniae, and E. faecium was previous exposure to antimicrobials. On the basis of these data, the use of fluoroquinolones should be reserved until culture data are available for the treatment of UTIs in South Korea. The present study will serve as a useful reference for Far Eastern Asia.
机译:这项研究旨在(i)研究门诊和住院患者中引起尿路感染(UTIs)的细菌的抗菌药敏性,以及(ii)评估韩国UTI中出现抗菌药物耐药性的危险因素。总共从25至65岁之间的女性中收集了3,023个重复样本,这些女性被诊断出患有尿路感染。使用基于Web的电子系统收集多中心患者数据,然后进行评估。门诊病人中大肠杆菌,肺炎克雷伯菌和粪便肠球菌的分离率分别为78.1%,4.7%和1.3%。在住院环境中,这些微生物的分离率分别为37.8、9.9和14.8%。在门诊患者中,大肠杆菌对阿米卡星,阿莫西林-克拉维酸,头孢噻肟,头孢西丁,环丙沙星,哌拉西林-他唑巴坦和亚胺培南的敏感性分别为99.4%,79.8、89.4、92.8、69.8、96.9和100.0%。在住院患者中,对这些抗生素的敏感性分别为97.8%,73.9、73.7、82.1、53.6、93.2和100.0%。出现抗药性大肠埃希菌,肺炎克雷伯菌和粪肠球菌的最独特,最常见的风险因素是以前曾接触过抗微生物剂。根据这些数据,应保留氟喹诺酮类药物的使用,直到韩国可获得用于治疗UTI的培养数据为止。本研究将为远东地区提供有用的参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号